Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract

NCT05396547 is registered in ClinicalTrials.gov with Edinburgh Biosciences Ltd as lead sponsor.

NCT NCT05396547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05396547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract
Lead sponsor
Edinburgh Biosciences Ltd
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2022
Completion date
February 2, 2025
Enrollment
114 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

age-related cataract